Inhaled therapy tested for rare Double-Lung condition
NCT ID NCT03814317
Summary
This study tested whether an inhaled medication called treprostinil could help people with sarcoidosis who have two related lung problems: scarring (interstitial lung disease) and high blood pressure in the lungs (pulmonary hypertension). The goal was to see if this targeted, inhaled treatment could improve heart and lung function with fewer side effects than pills. Five participants used the medication, and researchers measured changes in blood pressure in their lungs, walking distance, and other heart and lung tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida, Division of Pulmonary and Critical Care Medicine
Gainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.